Basal concentrations and responses to an oral glucose tolerance test of glucagon, GLP-1, GIP, CCK, and gastrin at baseline and after matched ~6% weight loss by a CD or a CRHP diet in individuals with T2D and overweight or obesity. The gene discussed is GCG; the disease is obesity disorder.